Quantcast

Lipitor Lawsuit News: Rottenstein Law Group LLP Comments on Lipitor’s Possible Link to Diabetes Risk

May 13, 2013

The firm is currently offering Lipitor lawsuit evaluations to women who have suffered from allegedly serious Lipitor side effects.

(PRWEB) May 13, 2013

The popular statin Lipitor has been the focus of a number of research studies, some of which have found a possible link between the drug and an increased risk of type 2 diabetes in women who use Lipitor to help lower their cholesterol levels, according to Reuters.* The Rottenstein Law Group LLP, a Lipitor law firm, offers its opinion on what the studies mean for those who have suffered from diabetes allegedly caused by Lipitor and who wish to file a Lipitor lawsuit.

A 2011 study published in the Journal of the American College of Cardiology found that those at risk of getting diabetes were more likely to be diagnosed with the disease when they were using Lipitor, a statin prescribed to reduce high cholesterol in patients, according to Reuters. Another study, published in the January 2012 edition of JAMA: Internal Medicine, indicated that there is a potential link between statins and a type 2 diabetes risk in women.**

“There has been a sizable amount of news coverage centered on the link between Lipitor and an increased diabetes risk,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “As more people become aware of the connection, more of them are considering their legal options. We receive calls daily from women who believe Lipitor has put them at risk.”

Plaintiffs across the country are filing Lipitor lawsuits, many of which are under consideration for consolidation into a federal multidistrict litigation for efficient pretrial proceedings (In re Lipitor (Atorvastatin) Litigation, MDL No. 2459 (Judicial Panel on Multidistrict Litigation)).

The Rottenstein Law Group LLP´s Lipitor Lawsuit Information Center offers a comprehensive look at Lipitor side effects and how to file a Lipitor lawsuit.

*reuters.com/article/2011/03/28/us-more-diabetes-idUSTRE72R67820110328 (March 28, 2011)

**archinte.jamanetwork.com/article.aspx?articleid=1108676 (January 2012)

For the latest news on defective medications and medical devices and related lawsuits, visit the Rottenstein Law Group LLP´s Injury Lawyer Newswire at http://www.injurylawyernewswire.com. Readers can subscribe to the news site´s stories and videos to stay on top of personal injury news.

About THE ROTTENSTEIN LAW GROUP LLP

The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and drugs. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:

The Rottenstein Law Group LLP

Rochelle Rottenstein, Esq.

321 W. 44th Street

# 804

New York NY 10036

(212) 933-9500 (office phone)

(212) 933-9980 (facsimile)

rochelle (at) rotlaw (dot) com

                            ###

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebside-effects-lipitor/lipitor-recall/prweb10723107.htm


Source: prweb



comments powered by Disqus